Peter Marks
Impact in
- Genetics top 1%
- Hemoglobinopathies and Related Disorders
- Hematology top 1%
- Iron Metabolism and Disorders
Papers in
- Hematology 26
- Iron Metabolism and Disorders 8
- Acute Myeloid Leukemia Research 6
- Co-authors
- Robert M. Califf (4 shared papers)Frederick R. Maxfield (4 shared papers)Janet Woodcock (2 shared papers)Steven A. Anderson (6 shared papers)Gerald J. Dal Pan (1 shared paper)Gerry Gray (1 shared paper)Danica Marinac‐Dabic (1 shared paper)Jeffrey Shuren (1 shared paper)
- Journals
- Blood (11 papers)New England Journal of Medicine (9 papers)Transfusion (5 papers)JAMA (5 papers)American Journal of Hematology (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter Marks
106 papers receiving 5.3k citations
Peter Marks's Hit Papers
Peers
Comparison fields: 5 of 165
- Genetics 625
- Hematology 622
- Immunology and Allergy 318
- Internal Medicine 152
- Oncology 698
Countries citing papers authored by Peter Marks
This map shows the geographic impact of Peter Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Marks more than expected).
Fields of papers citing papers by Peter Marks
This network shows the impact of papers produced by Peter Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Marks. The network helps show where Peter Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Real-World Evidence — What Is It and What Can It Tell Us? Hit paper breakdown → | 2016 | 1396 |
| 2 | 1999 | 324 | |
| 3 | 2003 | 257 | |
| 4 | 1990 | 240 | |
| 5 | 2006 | 225 | |
| 6 | 2016 | 212 | |
| 7 | Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy Hit paper breakdown → | 2021 | 201 |
| 8 | 2000 | 189 | |
| 9 | Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy Hit paper breakdown → | 2024 | 164 |
| 10 | 2004 | 124 | |
| 11 | 2002 | 124 | |
| 12 | 2018 | 121 | |
| 13 | 2014 | 105 | |
| 14 | 1991 | 101 | |
| 15 | 1991 | 99 | |
| 16 | 1990 | 87 | |
| 17 | 2002 | 85 | |
| 18 | 1998 | 75 | |
| 19 | 1996 | 74 | |
| 20 | 2013 | 67 |
About Peter Marks
Peter Marks is a scholar working on Molecular Biology, Hematology, Genetics, Infectious Diseases and Physiology, having authored 115 papers that have together received 5.5k indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (14 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Biomedical Ethics and Regulation (8 papers), Iron Metabolism and Disorders (8 papers), CAR-T cell therapy research (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Blood donation and transfusion practices (6 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Genetics (625 citations), Hematology (622 citations), Immunology and Allergy (318 citations), Internal Medicine (152 citations) and Oncology (698 citations). Peter Marks has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Robert M. Califf, Frederick R. Maxfield, Janet Woodcock, Steven A. Anderson, Gerald J. Dal Pan, Gerry Gray, Danica Marinac‐Dabic, Jeffrey Shuren, Thomas P. Gross and Lilly Q. Yue. Their work appears in journals such as Blood, New England Journal of Medicine, Transfusion, JAMA and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.